Search results
Orca Bio is a company developing next-generation cell therapies for blood diseases and severe autoimmune disease. Ivan Dimov, PhD, is the Chief Executive Officer and one of the co-founders of Orca Bio, with a background in stem cell research at Stanford University.
Ivan Dimov is a PhD engineer and entrepreneur who co-founded Orca Bio, a company developing high-precision cell therapies. He has experience in electronics, bio-micro-systems, and stem cell research, and speaks multiple languages.
- 500+
- 1.8K
- Ivan Dimov
Oct 29, 2021 · Let’s dive into the deep end with Ivan Dimov, PhD engineer, CEO, and cofounder of Orca Bio.
Ivan launched Orca Bio in 2016 and is Chief Executive Officer of Orca Bio. He is also cofounder and former Chief Technology Officer of Lucira Health, a molec...
- 14 min
- 256
- Axial
Jun 17, 2020 · Orca Bio is a biotechnology company developing high-precision allogeneic cell therapies for various diseases. Ivan Dimov, PhD, is the cofounder and CEO of Orca Bio, and leads a team of experts and investors with experience in drug discovery and cell-based therapeutics.
Ivan launched Orca Bio in 2016 and is Chief Executive Officer of Orca Bio. He is also cofounder and former Chief Technology Officer of Lucira Health, a molecular diagnostics company that received the first FDA authorization for a COVID-19 at-home self-testing kit.
Apr 5, 2024 · Ivan Dimov, co-founder & CEO of Orca Bio, and his team have created a novel cell therapy alternative that has already saved over 400 lives in clinical trials with virtually zero rejection! This week, we dive into Ivan's journey, the science behind Orca's cancer breakthrough, and the potential of cell therapies to cure a host of other ...
